acmefirewoodis...(put something here)
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$AMBS Presents at Biotech Showcase 2014
Today at 4:00 P.S.T.
http://www.media-server.com/m/p/i98tbt59
LOL!!! Still trying to get cheap shares. I told you to cover at .043.
Two major groups of investors are accumulating shares. Tens of millions of shares are being acquired. Started at .0415.
If you can cover under .11 I suggest you do so.
Twitter: @AmarantusBio
p.s. Rumor is that bankers and investors are on board for the up listing. Not if but when.
All you need to know about $AMBS: .01 downside versus .50 upside over the next six months.
It really is that simple.
Twitter: @AmarantusBio
Everyone should relax. Consolidating at .11 for the next move higher. The investors will never let this close below .10 again.
The shorts can't take it lower.
Twitter: @AmarantusBio
p.s. Add a few shares below .11 if you can.
In the words of famed radio announcer Paul Harvey: "Stay tuned for news!!!"
Biotech Showcase 2014
Wednesday, January 15, 2014, 4:00 pm PST
http://www.media-server.com/m/p/i98tbt59
Twitter: @AmarantusBio
Gerald plan is working to perfection and that's just what we currently know.
"Patience is a virtue."
The word is starting to get out about the company and its tremendous potential.
Twitter: @AmarantusBio
p.s. Expect a major "pop" on Thursday. Tomorrow evening is the SoCal Investor's Forum dinner at Morton's. Several analysts will be in attendance.
You are 100% correct in your assessment.
I think Gerald will do a 1 for 10 reverse split at .50 and move it to the NASDAQ at $5.00.
Within six months after the uplisting it will triple with a Becton Dickinson/LymPro partnership being the primary catalyst and development partnerships for MANF for Retinitis Pigmentosa and diabetes also contributing.
We're at the bottom of where this is headed.
"Patience is a virtue."
Twitter: @AmarantusBio
Amarantus BioScience Holdings at Biotech Showcase
2014 Wednesday, January 15, 2014, 4:00 pm PST
http://www.media-server.com/m/p/i98tbt59
Open at .13 tomorrow.
Heavy accumulation by SoCal investors. They've been buying heavily since .043.
Wish I had the opportunity to attend tomorrow's dinner. :(
This will continue up through the up listing and beyond.
Twitter: @AmarantusBio
p.s. This isn't the same company that it was six months ago.
This will be my last response to your post(s).
You are 100% clueless as to what is happening with the company.
My price predictions will all be correct. The time frames may be off a little.
.40 on June 1.
Twitter: @AmarantusBio
You left a 1 off the front of your target.
$1.16 in a year.
This will never go below .10. The investors are in for the long term.
SoCal Investor's meeting tomorrow evening.
Anyone who is waiting for a pullback will be left behind.
.15 by Friday is realistic.
Twitter: @AmarantusBio
The company will have about $13,000,000 in cash on hand by Valentine's Day!!!
"Patience is a virtue."
Twitter: @AmarantusBio
Gerald's plan is working to perfection.
Teenagers can be difficult but I think I can deal with $AMBS being above .13 tomorrow.
"Patience is a virtue."
Twitter: AmarantusBio
$AMBS - Amarantus BioScience Holdings at Biotech Showcase 2014
Wednesday, January 15, 2014, 4:00 pm PST
http://www.media-server.com/m/p/i98tbt59
.40 by June 1 is realistic.
Twitter: @AmarantusBio
Amarantus Licenses Phase 2b Ready Eltoprazine For PD-LID
http://seekingalpha.com/article/1944401-amarantus-licenses-phase-2b-ready-eltoprazine-for-pd-lid
"Over the next few months we believe the company will update investors on the clinical path for eltoprazine, as well as LymPro and MANF. We expect to provide investors with a better assessment of eltoprazine and the market opportunity at that time. In the meantime, we believe the fundamental improvements taking place at the company along with pending catalysts and a new flag-ship Phase 2b asset are poised to drive the shares significantly higher."
Twitter: @AmarantusBio
New Seeking Alpha Article from Jason Napadano?
Jason placed a "BUY" rating on $AMBS and a .20 price target on the stock. That was before the second orphan indication for MANF in the field of diabetes was known and before Gerald had disclosed the existence of a third one and before current timelines were known.
I would have to believe that we'll see a new article from Jason within the next week or two with a price target in the .35 range or higher and the focus being on anticipated catalysts for the company's up-listing within the next six months.
The stock continues to be under accumulation and the right news will double the share price. Not if but when.
It remains the most undervalued micro cap bio-tech in the market.
"Patience is a virtue."
Twitter: @AmarantusBio
p.s. I'm expecting additional analysts to start covering the company within the next three to four weeks with "Buy" or "Strong Buy" ratings.
Amarantus BioScience Holdings at Biotech Showcase 2014
Wednesday, January 15, 2014, 4:00 pm PST
http://www.media-server.com/m/p/i98tbt59
Twitter: @AmarantusBio
I think it's time for a few "Hole In Ones"!!!"
Twitter: @AmarantusBio
I think we'd all be surprised to know what opportunities Gerald is currently pursuing.
"Patience is a virtue."
Twitter: @AmarantusBio
Listen to Gerald's presentation today at the OneMed Forum at 2:30 PST:
http://www.onemedplace.com/forum/webcast/
It sucks when individuals aren't smart enough to buy at the bottom.
Neither your comments nor mine will impact the continued increase in the share price.
Great week ahead. Great months ahead. Great years ahead.
Gerald's plan is working.
Twitter: @AmarantusBio
The N.F.L. playoffs leading to the Super Bowl.
Have you been to Morton's in San Francisco?
Have a great weekend!!!
Twitter: @AmarantusBio
There's a lot more happening than just conferences over the next week or two.
Add a few shares at the open on Monday.
The current share price substantially undervalues the company according to Zacks' analyst, Jason Napadano, who has a "BUY" rating on the stocks and a price target more than double the current price.
I assume you already knew that.
Twitter: @AmarantusBio
p.s. ACAD went up over 1,500% last year. I recall many posters on the ACAD board were saying to sell when it hit $5.00. I expect the same thing will happen here when the share price goes above .15.
"Someone may offer you "X" today where as in three months they'll offer you a 100 times "X"."
Gerald's words to be remembered.
The week ahead:
OneMedForum SF 2014
Biotech Showcase 2014
Southern California Investment Forum
1. President & CEO Gerald Commissiong will present at OneMedForum at 2:30 PM PST on Monday, January 13, 2014 at the Westin Market Street. The presentation will be web cast live and available for replay at www.onemedplace.com/forum/webcast.
2. A Company representative will present at Biotech Showcase on Wednesday, January 15, 2014 at 4:00 PM PST at the Parc 55 Wyndham Hotel. This presentation may be viewed live and will by archived at http://www.media-server.com/m/p/i98tbt59.
3. An investment dinner presentation hosted by the Southern California Investment Forum (SCIF) will take place on Wednesday, January 15, 2014 at Morton's Steakhouse.
Company management and key advisors are available during this week in San Francisco for one-on-one meetings. If interested in scheduling a meeting, please contact ir@amarantus.com.
Exciting times ahead for the $AMBS shareholders.
Twitter: @AmarantusBio
p.s. The share price could easily double by Friday.
New high over .195 by the end of the month is very realistic.
Next week sets the stage for the continued up trend.
"Patience is a virtue."
Twitter: @AmarantusBio
p.s. I told the shorts to cover weeks ago.
Shorts keep digging their grave deeper and deeper.
This isn't going lower. Bottom is in place.
Enjoy the ride up to the up listing with major catalysts along the way.
Gerald's plan in in play.
Twitter: @AmarantusBio
Have a great weekend!!! I'll be back on Monday.
p.s. Next week the ride up from .10 begins.
The share price will hit .40 before it hits $1.00.
IMHO.
In and out and in and out!!!
No increase in production with lower price of gold means less revenues and greater operating loss.
I think it's headed back to the low .40's.
Time to take some profits.
All IMHO.
p.s. Don't be the last one out the door.
And the company will have $10,000,000 in cash on hand?
Once again you are wrong. It's only been since February of last year when I spoke with Gerald the first time.
I chuckled when I read "Don't make assumptions". Anyone who owns stocks is making an assumption.
I've spoken with him nine times and each time I'm more convinced as to the tremendous success that he will achieve with LymPro and MANF.
I last spoke with him on Friday. Exciting year ahead for the shareholders.
Amarantus will be the top performing small cap in 2014.
Twitter: @AmarantusBio
p.s. I suggest you buy a few shares before next Friday.
If you believe that deals are never announced during conferences then I might suggest a bit more research on your part.
You probably also believe that good news is never announced on a Friday.
Twitter: @AmarantusBio
p.s. It's obvious that RiskReturns168 is using his keen insight based on his meeting with Gerald to arrive at his conclusion(s).
BD LymPro Deal Announcement Next Week!
I spoke with Gerald after the LA Conference in early December. The last thing I asked him was: "Will shareholders be happy in February?" He said: "Oh, we will be in good shape by the time we have the Concussion Summit." He told me there would be a lot of announcements in the coming two months. I believe the one that will most move our stock price in the near term is the BD LymPro Deal. I believe they will announce a deal next week at one of the Conferences in SF. They will be having all their Board of Advisors there for questions, they are inviting analysts, they are feeding them at Morton's Steakhouse, etc, etc, It sounds like a perfect opportunity to announce the LymPro deal and significant upfront money. That will propel us up above .15 or .20 cents by itself! I think Gerald knew this is the catalyst in his pocket that gave him the confidence to structure the financing deal the way he did: 5 million in warrants coming to us after we trade above .10 cents for 20 days.
Now, can you imagine what all the other catalysts and announcements will do after we are sitting on 20 to 40 million in cash? Cash is King! Cash gives us confidence. But more importantly, cash gives big institutions confidence to take a large stake in our future. Once the LymPro deal is announced, all the other announcements will be amplified and their effect on our stock price will be multiplied!! I bet we go into the Concussion Summit over .20 cents. Gerald was right! We will be in good shape by then.
Note: Posted on the Yahoo AMBS board by RiskReturn168.
Anyone who believes in the company knows that a run to .195 and beyond could occur at any time and is very realistic even if it is a bit conservative.
Was Jason Napadano realistic when he put a buy rating on AMBS and a .20 valuation when it was trading below four cents?
As to any concerns about the "non believers" who cares as they are 100% irrelevant by definition.
Twitter: @AmarantusBio
Next week's events will be major catalysts for moving the share price higher.
Expect additional analysts to initiate coverage before the end of the month.
This is getting ready to duplicate the last run to .195. The next one takes it to a new high and then it trends higher from there.
Twitter: @AmarantusBio
Fair value is currently in the .22-.25 range.
That is how undervalued the company is currently.
Twitter: @AmarantusBio
"Patience is a virtue."
Above .10 on 1/17/2014.
Twitter: @AmarantusBio
p.s. Cover or buy before the next p.r.
4th "orphan indication" for MANF could be announced at any time.
If you're on the sidelines or short I suggest you buy or cover.
Have a great day!!!
Twitter: @AmarantusBio
p.s. The share price will be above .10 on 1/17/2014.